The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Xeljanz (tofacitinib)
Australian Public Assessment Report
Device/Product Name
Xeljanz
Active ingredients
Tofacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04843-1-3
Submission Type
Extension of indications
Decision
Approved